Kodiak Sciences, Inc. (KOD)
37.73
-1.39
(-3.56%)
USD |
NASDAQ |
Aug 28, 16:00
37.73
0.00 (0.00%)
After-Hours: 16:51
Kodiak Sciences Total Liabilities (Quarterly) : 195.72M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 195.72M |
| March 31, 2026 | 193.90M |
| December 31, 2025 | 194.15M |
| September 30, 2025 | 194.38M |
| June 30, 2025 | 186.44M |
| March 31, 2025 | 189.07M |
| December 31, 2024 | 185.29M |
| September 30, 2024 | 187.30M |
| June 30, 2024 | 187.07M |
| March 31, 2024 | 193.57M |
| December 31, 2023 | 213.59M |
| September 30, 2023 | 245.24M |
| June 30, 2023 | 251.18M |
| March 31, 2023 | 247.75M |
| December 31, 2022 | 230.46M |
| September 30, 2022 | 244.46M |
| June 30, 2022 | 250.97M |
| March 31, 2022 | 252.90M |
| Date | Value |
|---|---|
| December 31, 2021 | 240.90M |
| September 30, 2021 | 231.89M |
| June 30, 2021 | 218.17M |
| March 31, 2021 | 211.06M |
| December 31, 2020 | 206.60M |
| September 30, 2020 | 198.96M |
| June 30, 2020 | 120.17M |
| March 31, 2020 | 115.36M |
| December 31, 2019 | 13.51M |
| September 30, 2019 | 9.225M |
| June 30, 2019 | 8.256M |
| March 31, 2019 | 6.982M |
| December 31, 2018 | 5.356M |
| September 30, 2018 | 60.93M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 21.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 256.81M |
| Shareholders Equity (Quarterly) | 61.10M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 2.489 |
| Net Debt Paydown Yield | 0.12% |